Enrich Therapeutics Inc.

Enrich Therapeutics commercializes NIH-backed cell isolation platform to enhance global biomedical research at true single cell level. Our static cell isolation strategy enables cell sorting under desired micro-environment, real-time monitoring, stress-free capture and built-in validation during process. Our behavior-based-isolation would be extensively used and greatly facilitate the development of drug, CART, NGS and many other applications.